Speaker illustration

Doctor Tommaso Bucci

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
European Heart Rythm Association

Low-grade endotoxemia, oxidative stress and thrombotic events in patients with primary antiphospholipid syndrome.

Event: ESC Congress 2023

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Autoimmune disease and heart disease: clinical presentation and outcomes

Thumbnail

Statin use is associated with a lower risk of mortality in patients with malignant breast cancer treated with anthracyclines. A global federated health database analysis

Event: ESC Congress 2023

Topic: Cardiotoxicity of Drugs

Session: Statins, bempedoic acid and ezetimibe: novel findings

Thumbnail

C-reactive protein in Stroke-Heart-Syndrome: a propensity-matched analysis of a global federated health network.

Event: ESC Congress 2023

Topic: Neurologic Disorders and Heart Disease

Session: Psychiatric and neurologic disease: cardiovascular complications

Thumbnail

Risk of major cardiovascular events and bleeding in atrial fibrillation patients with chronic obstructive pulmonary disease treated with low dose azithromycin prophylaxis.

Event: ESC Congress 2023

Topic: Clinical

Session: Remodelling, prognosis, and outcomes in atrial fibrillation

Thumbnail

ABC (Atrial fibrillation Better Care) pathway in asian patients: an analysis from the prospective Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry.

Event: ESC Congress 2023

Topic: Clinical

Session: Atrial fibrillation: screening and outcomes

Thumbnail

Relationship between proprotein convertase subtilisin/kexin type 9 (PCSK9) and thrombotic events in primary antiphospholipid syndrome. The multicenter ATHERO-APS study.

Event: ESC Congress 2022

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Autoimmune/chronic inflammatory disorders and heart disease 2

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb